{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:00:48Z","timestamp":1762160448333},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,2,1]],"date-time":"1990-02-01T00:00:00Z","timestamp":633830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1990,2]]},"DOI":"10.1007\/bf02244401","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T16:29:18Z","timestamp":1131985758000},"page":"168-172","source":"Crossref","is-referenced-by-count":9,"title":["Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers"],"prefix":"10.1007","volume":"100","author":[{"given":"Anne","family":"Bourson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02244401_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0014-2999(86)90277-3","volume":"130","author":"A Argiolas","year":"1986","unstructured":"Argiolas A, Melis MR, Gessa GL (1986) Oxytocin: an extremely potent inducer of penile erection and yawning in male rats. Eur J Pharmacol 130:265\u2013272","journal-title":"Eur J Pharmacol"},{"key":"BF02244401_CR2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(87)90168-3","volume":"134","author":"A Argiolas","year":"1987","unstructured":"Argiolas A, Melis MR, Vargiu L, Gessa GL (1987) d(CH2)5Tyr(Me)-[Orn8]vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1\u201324). Eur J Pharmacol 134:221\u2013224","journal-title":"Eur J Pharmacol"},{"key":"BF02244401_CR3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.ne.10.030187.003221","volume":"10","author":"GJ Augustine","year":"1987","unstructured":"Augustine GJ, Charleton MP, Smith SJ (1987) Calcium action in synaptic transmitter release. Ann Rev Neurosci 10:633\u2013693","journal-title":"Ann Rev Neurosci"},{"key":"BF02244401_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(88)91328-5","volume":"438","author":"GT Bolger","year":"1988","unstructured":"Bolger GT, Lesieur P, Basile AS, Skolnick P (1988) Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain. Brain Res 438:101\u2013107","journal-title":"Brain Res"},{"key":"BF02244401_CR5","unstructured":"Bourson A, Moser PC (1989) Potentiation by dihydropyridine calcium channel blockers of physostigmine-induced yawning in rats. Br J Pharmacol 97:468P"},{"key":"BF02244401_CR6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(89)90089-7","volume":"160","author":"A Bourson","year":"1989","unstructured":"Bourson A, Moser PC, Gower AJ, Mir AK (1989a) Central and peripheral effects of the dihydropyridine calcium channel activator BAY K 8644 in the rat. Eur J Pharmacol 160:339\u2013347","journal-title":"Eur J Pharmacol"},{"key":"BF02244401_CR7","doi-asserted-by":"crossref","unstructured":"Bourson A, Gower AJ, Mir AK, Moser PC (1989b) The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity. Br J Pharmacol (in press)","DOI":"10.1111\/j.1476-5381.1989.tb12679.x"},{"key":"BF02244401_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/j.1552-4604.1983.tb02720.x","volume":"23","author":"TS Foster","year":"1983","unstructured":"Foster TS, Hamann SR, Richards VR, Bryant PJ, Graves DA, McAllister RG (1983) Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol 23:161\u2013170","journal-title":"J Clin Pharmacol"},{"key":"BF02244401_CR9","first-page":"229","volume":"26","author":"GL Gessa","year":"1967","unstructured":"Gessa GL, Pisano M, Vargiu L, Crabai F, Ferrari W (1967) Stretching and yawning movements after intracerebral injection of ACTH. Rev Can Biol 26:229\u2013236","journal-title":"Rev Can Biol"},{"key":"BF02244401_CR10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(87)90500-0","volume":"139","author":"AJ Gower","year":"1987","unstructured":"Gower AJ (1987) Effects of acetylcholine agonists and antagonists on yawning and analgesia in the rat. Eur J Pharmacol 139:79\u201389","journal-title":"Eur J Pharmacol"},{"key":"BF02244401_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(84)90192-4","volume":"103","author":"AJ Gower","year":"1984","unstructured":"Gower AJ, Berendsen HHG, Princen MM, Broekkamp CLE (1984) The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity. Eur J Pharmacol 103:81\u201389","journal-title":"Eur J Pharmacol"},{"key":"BF02244401_CR12","first-page":"633","volume":"40","author":"B Holmgren","year":"1980","unstructured":"Holmgren B, Urba-Holmgren R (1980) Interaction of cholinergic and dopaminergic influences on yawning behavior. Acta Neurobiol Exp 40:633\u2013642","journal-title":"Acta Neurobiol Exp"},{"key":"BF02244401_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00543969","volume":"32","author":"J Lobo","year":"1987","unstructured":"Lobo J, Jack DB, Kendall MJ (1987) Inter- and intra-subject variability of nitrendipine and the effects of food. Eur J Clin Pharmacol 32:357\u2013360","journal-title":"Eur J Clin Pharmacol"},{"key":"BF02244401_CR14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00498860","volume":"331","author":"DN Middlemiss","year":"1985","unstructured":"Middlemiss DN (1985) The calcium channel activator, BAY K 8644, enhances K+-evoked efflux of acetylcholine and noradrenaline from rat brain slices. Naunyn-Schmiedeberg's Arch Pharmacol 331:114\u2013116","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"BF02244401_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/314094a0","volume":"314","author":"DN Middlemiss","year":"1985","unstructured":"Middlemiss DN, Spedding M (1985) A functional correlate for the dihydropyrine binding site in rat brain. Nature 314:94\u201396","journal-title":"Nature"},{"key":"BF02244401_CR16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/cs0660249","volume":"66","author":"JA Millar","year":"1984","unstructured":"Millar JA, Struthers AD (1984) Calcium antagonists and hormone release. Clin Sci 66:249\u2013255","journal-title":"Clin Sci"},{"key":"BF02244401_CR17","unstructured":"Mogilnicka E, Czyrak A, Golembiowska K, Maj J (1988) Effect of some calcium channel antagonists and the calcium channel agonist BAY K 8644 in pharmacological models related to dopaminergic activity. Psychopharmacology 96:S364"},{"key":"BF02244401_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1748-1716.1986.tb07794.x","volume":"126","author":"O Nordstr\u00f6m","year":"1986","unstructured":"Nordstr\u00f6m O, Braesch-Andersen S, Bartfai T (1986) Dopamine release is enhanced while acetylcholine release is inhibited by nimodipine (Bay e 9736). Acta Physiol Scand 126:115\u2013119","journal-title":"Acta Physiol Scand"},{"key":"BF02244401_CR19","first-page":"217","volume":"42","author":"KD Ramsch","year":"1987","unstructured":"Ramsch KD, Lucker PW, Wetzelsberger N (1987) Pharmacokinetics of intravenously and orally administered nimodipine. Clin Pharmacol Ther 42:217","journal-title":"Clin Pharmacol Ther"},{"key":"BF02244401_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/303535a0","volume":"303","author":"M Schramm","year":"1983","unstructured":"Schramm M, Thomas G, Towart R, Franckowiak G (1983) Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 303:535\u2013537","journal-title":"Nature"},{"key":"BF02244401_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0091-3057(87)90118-3","volume":"26","author":"G Serra","year":"1987","unstructured":"Serra G, Fratta W, Collu M, Gessa GL (1987) Hypophysectomy prevents ACTH-induced yawning and penile erection in rats. Pharmacol Biochem Behav 26:277\u2013279","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244401_CR22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/BF00172963","volume":"95","author":"AJ Stoessl","year":"1988","unstructured":"Stoessl AJ, Dourish CT, Iversen SD (1988) The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation. Psychopharmacology 95:502\u2013506","journal-title":"Psychopharmacology"},{"key":"BF02244401_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/267261a0","volume":"267","author":"R Urba-Holmgren","year":"1977","unstructured":"Urba-Holmgren R, Gonzalez RM, Holmgren B (1977) Is yawning a cholinergic response? Nature 267:261\u2013262","journal-title":"Nature"},{"key":"BF02244401_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(84)90229-6","volume":"21","author":"I Ushijima","year":"1984","unstructured":"Ushijima I, Yamada K, Inoue T, Tokunaga T, Furukawa T, Noda Y (1984) Muscarinic and nicotinic effects on yawning and tongue protruding in the rat. Pharmacol Biochem Behav 21:297\u2013300","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02244401_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00427593","volume":"67","author":"K Yamada","year":"1980","unstructured":"Yamada K, Furukawa T (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology 67:39\u201343","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02244401\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02244401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:32:02Z","timestamp":1557862322000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02244401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,2]]}},"alternative-id":["BF02244401"],"URL":"https:\/\/doi.org\/10.1007\/bf02244401","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,2]]}}}